Found: 10
Select item for more details and to access through your institution.
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 5, p. 539, doi. 10.1002/ajh.25435
- By:
- Publication type:
- Article
309 MYC Inhibition Overcomes IMiD Resistance in Heterogeneous Multiple Myeloma Populations.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Monoclonal Antibodies in Multiple Myeloma: A New Wave of the Future.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Lenalidomide‐induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosis.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Applying the discovery of the Philadelphia chromosome.
- Published in:
- Journal of Clinical Investigation, 2007, v. 117, n. 8, p. 2067, doi. 10.1172/JCI31988
- By:
- Publication type:
- Article
A case for improving frail patient outcomes in multiple myeloma with phenotype‐driven personalized medicine.
- Published in:
- Aging & Cancer, 2021, v. 2, n. 1, p. 6, doi. 10.1002/aac2.12022
- By:
- Publication type:
- Article
Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic Paradigm.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.925818
- By:
- Publication type:
- Article
CD46–ADC Reduces the Engraftment of Multiple Myeloma Patient-Derived Xenografts.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5335, doi. 10.3390/cancers15225335
- By:
- Publication type:
- Article
Emerging Therapeutic Strategies to Overcome Drug Resistance in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1686, doi. 10.3390/cancers13071686
- By:
- Publication type:
- Article